Pressure ulcers (PUs) negatively affect quality of life (QoL) and cause problems for patients, such as pain, distress and often specific difficulties with treatments used to manage the wound. Thus, it is important to implement appropriate prevention strategies in order to achieve high-quality care, thereby reducing the burden of PUs on patients, the healthcare system and society as a whole. PU development arises due to the adverse effects of pressure, shear, friction and moisture at the skin/surface interface. Preventive interventions typically include risk assessment, reducing pressure and minimising shear and friction. More recently, certain wound dressings, as a potential additional protective strategy for preventing PUs, have been introduced. This review explores the mechanisms of action of dressings for preventing PUs. Findings from the review indicate that decreasing frictional forces transmitted to the patient's skin is achieved by use of a dressing with an outer surface made from a low friction material. Furthermore, the ability of dressings to absorb and redistribute shear forces through good adhesion to the skin, high loft and lateral movement of the dressing layers is important in reducing shear forces. This is achieved when the dressing reduces pressure transmitted to the patient's tissues by the propriety of high loft/thickness and padding that allows a degree of cushioning of bony prominences. Further, dressings may reduce humidity at the skin/dressing interface, i.e., the dressing is absorbent and/or permits moisture to evaporate quickly. As part of an established PU prevention protocol, dressings may help decrease PU incidence.
A pressure ulcer (PU) is acknowledged as a common pathology across healthcare settings. PUs are described as localised damage to the skin and/or underlying tissue, and it is believed that pressure and shear are the primary cause.1 Global mean PU point prevalence in public hospitals is shown to be 14.8% (standard deviation (SD)±8.24), ranging from 2.20% to 40%.2 More recently, the median prevalence of PUs in Europe was reported as 10.8% (SD±7%; range: 4.6–27.2%).3
PUs negatively affect a patient's quality of life (QoL) with reported problems including pain and difficulties with treatments used to manage the wound. PUs are also expensive to manage, and a major challenge with PU treatment and management costs is that they compete with strategies attempting to ensure cost-effective, efficient health service delivery.4,5,6 The cost of PU prevention per patient, per day, is between €2.65 and €87.57, whereas, the cost of treatment ranges from €1.71 to €470.49. Thus, prevention of PUs can contribute to cost-effective care delivery.7
Register now to continue reading
Thank you for visiting Wound Care Professional and reading some of our peer-reviewed resources for wound care professionals. To read more, please register today. You’ll enjoy the following great benefits:
Access to clinical or professional articles
New content and clinical updates each month